Chromosome |
Candidate target gene and their location |
Aberration type |
Reference |
1q |
CSK1B(1q21.2)
|
Gain |
[88, 89] |
CHD1L(1q21.1)
|
JTB(1q21)
|
MDM4(1q32.1)
|
1p |
p18(1p32)
|
Loss |
[90-92] |
p73(1p36.3)
|
RIZ(1p36.13-p36.23)
|
3q |
Gankyrin (3q28)
|
Gain |
[33] |
3p |
ROSSF1A(3p21.3)
|
Loss of heterogeneity, CpG methylation |
[93, 94] |
CTNNB1(3p21)
|
TGF-1βR11(3q22)
|
4q |
|
Loss of heterogeneity |
[95] |
6p |
|
Gain |
[96] |
6q |
M6P/IGF2R (6q26-q27)
|
Loss of heterogeneity |
[97] |
8q |
c-Myc (8q24.21)
|
Gain |
[98.99,100] |
PTK2 (8q24.3)
|
EIF3S3 (8q23.3)
|
SGK3 (8q13.1)
|
8p |
DLC-1 (8p21.3-22)
|
Loss of heterogeneity, CpG methylation |
[101] |
LPTS (8p23)
|
CSMD1 (8p23.2)
|
9p |
CDKN2A (9p21)
|
Loss of heterogeneity, CpG methylation |
[102] |
CDKN2B (9q21)
|
11q |
cyclinD1 (11q13)
|
Gain |
[103] |
10q |
PTEN/MMAC1 (10q23.3)
|
Loss of heterogeneity |
[104] |
11p |
KAI1 (11p11.2)
|
Loss of heterogeneity, CpG methylation |
[105] |
IGF-2 (11p15)
|
TSLC1 (11p23.2)
|
13q |
Rb1 (13q14.2)
|
Loss of heterogeneity |
[106, 107] |
BRCA2 (13q12.3)
|
Tg737 (13q12.1)
|
TFDP1 (13q34)
|
CUL4A (13q34)
|
CDC1 (13q34)
|
16q |
CDH1 (16q22.1)
|
Loss of heterogeneity, CpG methylation |
[102] |
16p |
Axin1 (16p13.3)
|
CpG methylation |
[108] |
SOCS-1 (16p13.3)
|
17p |
p53 (17p13.1)
|
Loss of heterogeneity |
[103, 109] |
HIC-1 (17p13.3)
|
HCCS1 (17p13.3)
|